On this page
Evidence dossier
The report behind the claim
The authors reported changes in platelet aggregation while several clot-viscoelasticity tests were unchanged. Altered laboratory platelet response is not proof of fewer clinical bleeds or clots.
Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats receiving aspirin, clopidogrel or cilostazol
- Endpoint
- Platelet aggregation and thromboelastometry
- Finding on record
- The authors reported changes in platelet aggregation while several clot-viscoelasticity tests were unchanged.
- Limits of inference
- Altered laboratory platelet response is not proof of fewer clinical bleeds or clots.
The experiment in view
The study used rats receiving aspirin, clopidogrel or cilostazol. Its principal measures were platelet aggregation and thromboelastometry. The authors reported changes in platelet aggregation while several clot-viscoelasticity tests were unchanged.
Reading the result closely
The unchanged tests are part of the result. A broad claim of balanced coagulation would omit the difference between platelet aggregation and other clot measurements. Readers taking prescribed antiplatelet treatment should not infer that another compound can safely reverse or optimize its action.
The boundary of the finding
Altered laboratory platelet response is not proof of fewer clinical bleeds or clots.
Related evidence, kept separate
BPC-157 after dextran or egg-related animal challenges examines swelling, respiration and short-term mortality-related observations. Here, the measured endpoint was platelet aggregation and thromboelastometry. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with The clopidogrel rat experiment: drug-related injury is not a combination recommendation appraisal.
On the record
The documents supporting this report.